Registered entities
Aurinia Pharmaceuticals Inc.
Reg. No. 1600620United States
AURINIA PHARMA U.S., INC.
Reg. No. 464129078United States
Innovation
19 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 2,775 times.
| Year | Filings |
|---|---|
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 10 |
| 2025 | 3 |
| 2026 | 3 |
Social engagement
Social engagement: 28.7K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 42% |
| Private equity | 2 | 17% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 4 | 33% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
10 Feb 2026 · Junior Accountant · Edmonton
29 Apr 2025 · Clinical QA Specialist (Contract) · Edmonton
Based on job postings tracked across public sources.
Recent activity
7 May 2026
Milestone
revenue
13 Feb 2026
Event
Lupus nephritis care webinar